. ROC analysis of the four-long non-coding RNA signature in predicting the overall survival rate of patients with different breast cancer stages. 
. ROC analysis of the four-long non-coding RNA signature in predicting the overall survival of patients with different breast cancer subtypes. (A) ROC curves of luminal-A subtype. (B) ROC curves of luminal-B subtype. (C) ROC curves of HER2-amplified subtype. (D) ROC curves of triple-negative subtype. HER2, human epidermal growth factor receptor 2; ROC, receiver operating characteristic; AUC, area under the curve. 
